Safety and efficacy of favipiravir for the management of COVID-19 patients: A preliminary randomized control trial

Safety and efficacy of favipiravir for the management of COVID-19 patients: A preliminary randomized control trial

Background: The novel coronavirus disease, commonly called COVID-19, has already killed millions of lives. Our study aimed to identify a safe and right drug for the management of such globally threatened COVID-19. Methods: This preliminary double-blinded randomized controlled trial was done among 57...

Full description

Bibliographic Details
Main Authors: S.M. Abdur Rahman, Ahmedul Kabir, A.B.M. Abdullah, Md Billal Alam, Khan Abul Kalam Azad, Md Titu Miah, Syed Ghulam Mogni Mowla, Sudip Ranjan Deb, Mohammad Robed Amin, Muhammad Asaduzzaman
Format: Article
Language:English
Published: Elsevier 2022-07-01
Series:Clinical Infection in Practice
Subjects:
Bangladesh
COVID-19
Favipiravir
Infectious disease
SARS-CoV-2
Online Access:http://www.sciencedirect.com/science/article/pii/S2590170222000139

Internet

http://www.sciencedirect.com/science/article/pii/S2590170222000139

Similar Items